Coloplast Affirms FY2026 Sales Guidance of $4.499B vs $4.420B Est

Benzinga Newsdesk www.benzinga.com Positive 62.2%

Neg 0% Neu 0% Pos 62.2%

Coloplast (OTC:CLPBY) affirms FY2026 sales outlook from $4.499 billion to $4.499 billion vs $4.420 billion estimate.

Comments

No comments yet. Be the first!